Biomarkers in Medicine

Novel Applications of Biomarkers in Chronic Obstructive Pulmonary Disease

Author(s): Pelin Uysal *

Pp: 425-439 (15)

DOI: 10.2174/9789815040463122010017

* (Excluding Mailing and Handling)


Chronic obstructive pulmonary disease (COPD) is an important health problem and an increasing cause of morbidity and mortality worldwide. Currently, COPD is considered a multisystem disease. Although it primarily affects the lungs, structural and functional changes occur in other organs due to systemic inflammation. It is stated that in patients with COPD, airway and systemic inflammatory markers are increased and that these markers are high are associated with a faster decline in lung functions. In recent years, numerous articles have been published on the discovery and evaluation of biomarkers in COPD. Many markers have also been studied to accurately assess COPD exacerbations and provide effective treatment. However, based on the evidence from published studies, a single molecule has not been adequately validated for broad clinical use.

Keywords: Chronic obstructive pulmonary disease, Biomarkers, Exacerbation, Therapy.

Related Journals
Related Books
© 2024 Bentham Science Publishers | Privacy Policy